These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Cure of hypoglycemic hyperinsulinism by enucleation of a focal islet cell adenomatous hyperplasia. Craver RD; Hill CB J Pediatr Surg; 1997 Oct; 32(10):1526-7. PubMed ID: 9349791 [TBL] [Abstract][Full Text] [Related]
11. Postprandial hypoglycemia in islet beta cell hyperplasia with adenomatosis of the pancreas. Tibaldi JM; Lorber D; Lomasky S; Steinberg JJ; Reisman R; Shamoon H J Surg Oncol; 1992 May; 50(1):53-7. PubMed ID: 1573895 [TBL] [Abstract][Full Text] [Related]
12. GLP-1 metabolite GLP-1(9-36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion. Gandasi NR; Gao R; Kothegala L; Pearce A; Santos C; Acreman S; Basco D; Benrick A; Chibalina MV; Clark A; Guida C; Harris M; Johnson PRV; Knudsen JG; Ma J; Miranda C; Shigeto M; Tarasov AI; Yeung HY; Thorens B; Asterholm IW; Zhang Q; Ramracheya R; Ladds G; Rorsman P Diabetologia; 2024 Mar; 67(3):528-546. PubMed ID: 38127123 [TBL] [Abstract][Full Text] [Related]
13. Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients. Rickels MR; Mueller R; Markmann JF; Naji A J Clin Endocrinol Metab; 2009 Jan; 94(1):181-9. PubMed ID: 18957498 [TBL] [Abstract][Full Text] [Related]
14. Exendin-(9-39) corrects fasting hypoglycemia in SUR-1-/- mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion. De León DD; Li C; Delson MI; Matschinsky FM; Stanley CA; Stoffers DA J Biol Chem; 2008 Sep; 283(38):25786-93. PubMed ID: 18635551 [TBL] [Abstract][Full Text] [Related]
15. Chromanol 293B, an inhibitor of KCNQ1 channels, enhances glucose-stimulated insulin secretion and increases glucagon-like peptide-1 level in mice. Liu L; Wang F; Lu H; Ren X; Zou J Islets; 2014; 6(4):e962386. PubMed ID: 25437377 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of glucagon secretion. Young A Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545 [TBL] [Abstract][Full Text] [Related]
17. Insulin-secreting islet cell tumors: establishing a diagnosis and the clinical course for 25 dogs. Kruth SA; Feldman EC; Kennedy PC J Am Vet Med Assoc; 1982 Jul; 181(1):54-8. PubMed ID: 6286582 [TBL] [Abstract][Full Text] [Related]
18. [Neonatal hypoglycemia due to hyperinsulinism secondary to Langerhans' polyadenomatosis. Recovery after pancreatectomy]. Babinet JM; Labrune B; Vignes B; Thibaud D; Valayer J; Tichet J; Gubler JP Arch Fr Pediatr; 1975; 32(6):515-31. PubMed ID: 170877 [TBL] [Abstract][Full Text] [Related]
19. GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K+ channel. Calabria AC; Li C; Gallagher PR; Stanley CA; De León DD Diabetes; 2012 Oct; 61(10):2585-91. PubMed ID: 22855730 [TBL] [Abstract][Full Text] [Related]
20. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]